As non-specific antivirals the benefits of these drugs are most likely at disease onset or as preventives. A trial has started in the US for people with known e

As non-specific antivirals the benefits of these drugs are most likely at disease onset or as preventives. A trial has started in the US for people with known exposure: https://clinicaltrials.gov/ct2/show/NCT04308668?term=hydroxychloroquine&recrs=ab&cond=COVID-19&draw=2&rank=4 https://clinicaltrials.gov/ct2/show/NCT04308668?term=hydroxy... Note the dosage being trialed is quite high. Definitely not something to do without proper medical supervision.